e-learning
resources
Berlin 2001
Sunday 23.09.2001
BAL / induced sputum / breath condensate in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety and effectiveness of sputum induction in chronic obstructive pulmonary disease
M. Maskey- Warzêchowska, J. J. Domagala-Kulawik, I. Kraszewska, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2001 - BAL / induced sputum / breath condensate in lung disease
Session:
BAL / induced sputum / breath condensate in lung disease
Session type:
Thematic Poster Session
Number:
523
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Maskey- Warzêchowska, J. J. Domagala-Kulawik, I. Kraszewska, R. Chazan (Warsaw, Poland). Safety and effectiveness of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2001; 16: Suppl. 31, 523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
Inferon efficacy in the treatment of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Efficacy and safety of bacterial lysates in patients with chronic obstructive pulmonary disease and exacerbation
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
The usefulness of pedometry in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
Tiotropium in the management of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 205-206
Year: 2002
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 107s
Year: 2006
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009
Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy
Source: Annual Congress 2006 - COPD – the challenges for primary care
Year: 2006
Clinical and inflammatory features of exacerbations of occupational chronic obstructive pulmonary disease
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Microbiological screening infectious exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.
Source: Eur Respir J 2003; 21: 912
Year: 2003
Relationship between proteases/anti-proteases system in induced sputum and spirometry testing in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 634s
Year: 2006
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept